Pharmafile Logo

Moorfields Pharmaceuticals

Moorfields Pharmaceuticals is the manufacturing arm of Moorfields Eye Hospital NHS Foundation Trust. We produce nearly 100 ophthalmic specials and have a growing portfolio of branded licensed products. Moorfields Eye Hospital has provided products in response to clinical needs for over 50 years, from just a handful of pharmacists within the hospital, we now employ more than 75 people.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

25 Provost Street, London, N1 7NH, United Kingdom
+44 (0)20 7684 9090

 Latest Content from PMHub 

Patient-Centricity: Improving the model with patient journeys

Head of Customer Experience Elisa del Galdo takes us through a better way to look at patient-centricity: with the patient's journey at the centre.

Four Communications acquires Healthcare specialist MSA Media

Press Releases | September 9, 2015 | Four Health

Independent integrated communications agency, Four Communications Group has acquired 100 per cent of market-leading healthcare media planning & buying agency MSA Media.

The vitamin D deficiency: should we act?

Healthcare PR agency Say Communications analyses whether headlines are able to trigger a behavioural change with regards to the vitamin D deficiency issue.

Is obesity the new smoking?

Is obesity the new smoking? The healthcare PR team at Say communications analyses the question posed by NHS Chief executive Simon Stevens.

Children, the weight issue and how we deal with this responsibly?

Say Communication, Healthcare PR Agency, looks at how children deal with the weight issue and how we can approach it responsibly.

Longevity but at what price?

Say Communications, healthcare PR agency, analyses the prospect of living to 150 years old, thanks to the anti-ageing biomedical research, and what PR will look like.

Competition from within

Published in eyeforpharma July 29 by Rachel Howard

Infographic: RA Perceptions

HCPs predict the future of the biologics market